Public Market Listing
4547TSE
Live quotes, historical charts, and market capitalization for Kissei Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
JR-131No recent activity | Phase 3 | Erythropoietin receptor (EPO-R)Biologic (subtype unspecified) | Chronic Kidney Disease |
Mitiglinide(Glufast) | Phase 3 | SUR1 (short-acting)Small molecule | Type 2 Diabetes |
| Phase 2 | Undisclosed / early pipelineSmall molecule | Inflammatory Bowel Disease Ulcerative Colitis | |
| Phase 2 | D2/D3Small molecule | Parkinson's Disease |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.